Adage Capital Partners Gp, L.L.C. Edwards Lifesciences Corp Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 453,266 shares of EW stock, worth $34.4 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
453,266
Previous 1,223,893
62.97%
Holding current value
$34.4 Million
Previous $90.6 Million
63.74%
% of portfolio
0.06%
Previous 0.17%
Shares
30 transactions
Others Institutions Holding EW
# of Institutions
1,376Shares Held
486MCall Options Held
2.77MPut Options Held
2.05M-
Vanguard Group Inc Valley Forge, PA69.2MShares$5.25 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.87 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$2.21 Billion0.42% of portfolio
-
State Street Corp Boston, MA25.8MShares$1.96 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY22MShares$1.67 Billion0.12% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $46.9B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...